Cellular vulnerability in brain aging and Alzheimer's disease: Clinical correlates and molecular background

Annales de Medecine Interne

Volumn 149, Issue 4, 1998, Pages 187-191

  Giannakopoulos, Panteleimon ^a   Gold, Gabriel ^a   Michel, Jean Pierre ^a   Bouras, Constantin ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Alzheimer; Brain aging; Centenarians; Neuropathology

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; AMNESIA; DISEASE PREDISPOSITION; HIPPOCAMPUS; HUMAN; NEOCORTEX; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; REVIEW; SENILE PLAQUE; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CELL SURVIVAL; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NERVE NET; SENILE PLAQUES; TEMPORAL LOBE;

EID: 0031830214     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. ARNOLD SE, HYMAN BT, FLORY J, DAMASIO AR, VAN HOESEN GW: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex, 1991; 1: 103-16.
2. BRAAK H, BRAAK E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991; 82: 239-59.
3. GIANNAKOPOULOS P, HOF PR, MOTTIER S, MICHEL JP, BOURAS C: Neuropathologic changes in the neocortex of 1258 cases from a geriatric hospital: retrospective clinicopathologic evaluation of a ten year autopsy population. Acta Neuropathol. 1994; 87: 456-68.
4. HOF PR, COX K, MORRISON JH: Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol, 1990; 301: 44-54.
5. LEWIS DA, CAMPBELL MJ, TERRY RD, MORRISON JH: Laminar and regional distribution of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J Neurosci, 1987; 7: 1799-808.
6. PEARSON RCA, ESIRI MM, HIORNS RW, WILCOCK GK, POWELL TPS: Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA, 1985; 82; 4531-4.
7. ROGERS J, MORRISON JH: Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci, 1985; 5: 2801-8.
8. ZOLA-MORGAN S, SQUIRE LR, REMPEL NL, CLOWER RP, AMARAL DG: Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J Neurosci, 1992; 12: 2582-96.
9. ARRIAGADA PV, GROWDON JH, HEDLEY-WHITE ET, HYMAN BT: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology, 1992; 42: 631-9.
10. BOURAS C, HOF PR, MORRISON JH: Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes. Neurosci Lett, 1993; 153: 131-5.
11. CRYSTAL H, DICKSON D, FULD P, et al.: Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology, 1988; 38: 1682-7.
12. DICKSON DW, CRYSTAL HA, MATTIACE LA, et al.: Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging, 1991; 13: 179-89.
13. MANN DMA, BROWN AMT, PRINJA D, JONES D, DAVIES CA: A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol, 1990; 16: 17-25.
14. MORRIS JC, MCKEEL JDW, STORANDT M, et al.: Very-mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology, 1991; 41: 469-78.
15. PRICE JL, DAVIS PB, MORRIS JC, WHITE DL: The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging, 1991; 12: 295-312.
16. ARRIAGADA PV, MARZLOFF K, HYMAN BT: Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology, 1992; 42: 1681-8.
17. CROOK T, BARTUS RT, FERRIS SH, WHITEHOUSE P, COHEN GD, GERSHON S: Age-associated memory impairment: proposed diagnositc criteria and measures of clinical change - report of a National Institute of Mental Health Group. Dev Neuropsychol, 1986; 4: 261-76.
18. HOF PR, BIERER LM, PERL DP, et al.: Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia - Regional and laminar distribution of neurofibrillary tangles and senile plaques. Arch Neurol, 1992; 49: 946-53.
19. BOURAS C, HOF PR, GIANNAKOPOULOS P, MICHEL J-P, MORRISON JH: Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex, 1994; 4: 138-50.
20. HOF PR, GIANNAKOPOULOS P, BOURAS C: The neuropathological changes associated with normal brain aging. Histol. Histopathol. 1996; 11: 1075-88.
21. 1. GIANNAKOPOULOS P, HOF PR, KÖVARI E, VALLET PG, BOURAS C: Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J Neuropathol Exp Neurol. 1996; 55: 1210-20.
22. GIANNAKOPOULOS P, HOF PR, SURINI M, MICHEL JP, BOURAS C: Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol, 1993; 85: 601-10.
23. DELAERE P, HE Y, FAYET G, DUYCKAERTS C, HAUW JJ: Beta A4 deposits are constant in the brain of the oldest old: an immunohistochemical study of 20 French centenarians. Neurobiol Aging, 1993; 14: 191-4.
24. GIANNAKOPOULOS P, HOF PR, GIANNAKOPOULOS AS, et al. Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia, 1994; 5: 348-56.
25. GIANNAKOPOULOS P, HOF PR, GIANNAKOPOULOS A-S, HERMANN F, MICHEL JP, BOURAS C: Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol, 1995; 52: 1150-9.
26. BERG L, MCKEEL DW, MILLER P, BATY J, MORRIS JC: Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol, 1993; 50: 349-58.
27. BIERER LM, HOF PR, PUROHIT DP, et al.: Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol, 1995; 52: 81-8.
28. HYMAN BT, VAN HOESEN GW, DAMASIO AR: Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology, 1990; 40: 1721-30.
29. MEUNIER M, BACHEVALIER J, MISHKIN M, MURRAY EA: Effects on visual recognition of combined and separate ablations of the entorhinal and perirhinal cortex in rhesus monkeys. J Neurosci, 1993; 13: 5418-32.
30. MORRIS RG, ANDERSON E, LYNCH GS, BAUDRY M: Selective impairment of learning and blockade of long-term potentiation by a N-methyl-D-aspartate receptor antagonist, AP5. Nature, 1986; 319: 774-6.
31. GAZZALEY AH, SIEGEL SJ, KORDOWER JH, MUFSON EJ, MORRISON JH: Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys. Proc Natl Acad Sci USA, 1996; 93: 3121-5.
32. MORRISON JH, HOF PR: Life and death of neurons in the aging brain. Science, 1997; 278: 412-9.
33. HOF PR, GIANNAKOPOULOS P, VICKERS JC, BOURAS C, MORRISON JH: The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution, and vulnerable neuronal phenotype. Rev Neurosci, 1995; 6: 97-124.
34. DE SILVA RHA, PATEL AJ: Presenilins and early-onset familial Alzheimer's disease. Neuroreport, 1997; 8: 1-11.
35. GIANNAKOPOULOS P, HOF PR, MICHEL JP, GUIMON J, BOURAS C: Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Rev, 1997; 25: 217-45.
36. SHEN J, BRONSON RT, CHEN DF, XIA W, SELKOE DJ, TONEGAWA S: Skeletal and CNS defects in presenilin-1-deficient mice. Cell, 1997; 89: 629-39.
37. GUO Q, SOPHER BL, FURUKAWA K, et al.: Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci, 1997; 17: 4212-22.
38. KIM TW, PETTINGELL WH, JUNG YK, et al.: Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 1997; 277: 373-6.